• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Forte Biosciences, Inc. - Common Stock (NQ:FBRX)

27.01 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 27.01
Bid (Size) 10.81 (200)
Ask (Size) 42.94 (100)
Prev. Close 27.01
Today's Range 27.01 - 27.01
52wk Range 4.900 - 35.62
Shares Outstanding 21,051,195
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
March 17, 2026
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
March 04, 2026
From Forte Biosciences, Inc.
Via Business Wire

Performance

YTD
+14.4%
+14.4%
1 Month
-5.2%
-5.2%
3 Month
-3.1%
-3.1%
6 Month
+89.5%
+89.5%
1 Year
+229.4%
+229.4%

More News

Read More
News headline image
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 09, 2026
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
December 22, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
November 24, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
November 14, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
November 03, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
October 03, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
September 15, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences Tops Q2 Loss Forecasts ↗
August 14, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Forte Biosciences, Inc. Announces Results and Provides Update
August 14, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
June 25, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
June 25, 2025
Via Benzinga
News headline image
Forte Biosciences Announces Pricing of $75 Million Public Offering
June 25, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
June 24, 2025
Via Benzinga
News headline image
Forte Biosciences Announces Proposed Public Offering
June 24, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
June 23, 2025
Via Benzinga
News headline image
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
June 23, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
May 27, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
May 19, 2025
Via Benzinga
News headline image
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗
May 19, 2025
Via Benzinga
News headline image
Forte Biosciences, Inc. Announces Results and Provides Update
May 15, 2025
From Forte Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
April 23, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
April 07, 2025
Via Benzinga
News headline image
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
From Forte Biosciences, Inc.
Via Business Wire

Frequently Asked Questions

Is Forte Biosciences, Inc. - Common Stock publicly traded?
Yes, Forte Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Forte Biosciences, Inc. - Common Stock trade on?
Forte Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Forte Biosciences, Inc. - Common Stock?
The ticker symbol for Forte Biosciences, Inc. - Common Stock is FBRX on the Nasdaq Stock Market
What is the current price of Forte Biosciences, Inc. - Common Stock?
The current price of Forte Biosciences, Inc. - Common Stock is 27.01
When was Forte Biosciences, Inc. - Common Stock last traded?
The last trade of Forte Biosciences, Inc. - Common Stock was at 03/26/26 04:00 PM ET
What is the market capitalization of Forte Biosciences, Inc. - Common Stock?
The market capitalization of Forte Biosciences, Inc. - Common Stock is 568.59M
How many shares of Forte Biosciences, Inc. - Common Stock are outstanding?
Forte Biosciences, Inc. - Common Stock has 569M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap